|
⚲
|
| Keyboard |
| Keith Katkin | |
|---|---|
| Firm | |
| Address | 4660 La Jolla Village Drive Suites 100 200 San Diego, CA 92122 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Transposon Therapeutics Inc | 021-518803 | Director | 4.7 M of 20.0 M |
||
| Eledon Pharmaceuticals Inc | 021-514042 | Director | 50.0 M | ||
| Eledon Pharmaceuticals Inc | 021-482292 | Director | 35.0 M | ||
| Transposon Therapeutics Inc | 021-469103 | Director | 5.0 M of 20.0 M |
||
| Novus Therapeutics Inc | 021-376405 | Director | 108.1 M of 108.1 M |
||
| Novus Therapeutics Inc | 021-359033 | Director | 0.9 M of 5.8 M |
||
| Novus Therapeutics Inc | 021-339368 | Director | 0.9 M of 28.5 M |
||
| MC10 Inc | 021-300654 | Director | 15.0 M of 25.0 M |
||
| MC10 Inc | 021-289346 | Director | 9.2 M of 10.0 M |
||
| MC10 Inc | 021-276455 | Director | 5.0 M of 5.0 M |
||
| Carbylan Therapeutics Inc | 021-235286 | Director | 4.0 M of 4.0 M |
||